These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 32955963)

  • 1. Adherence to international recommendations in the governance and organisation of Nordic cervical cancer screening programmes.
    Partanen VM; Heinävaara S; Waldstrøm M; Elfström KM; Tropé A; Ágústsson ÁI; Thorsteinsdottir S; Skare GB; Lönnberg S
    Acta Oncol; 2020 Nov; 59(11):1308-1315. PubMed ID: 32955963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 50 years of screening in the Nordic countries: quantifying the effects on cervical cancer incidence.
    Vaccarella S; Franceschi S; Engholm G; Lönnberg S; Khan S; Bray F
    Br J Cancer; 2014 Aug; 111(5):965-9. PubMed ID: 24992581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospects for phase III-IV HPV vaccination trials in the Nordic countries and in Estonia.
    Lehtinen M; Kibur M; Luostarinen T; Anttila A; Pukkala E
    J Clin Virol; 2000 Oct; 19(1-2):113-22. PubMed ID: 11091154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An overview of cervical cancer epidemiology and prevention in Scandinavia.
    Pedersen K; Fogelberg S; Thamsborg LH; Clements M; Nygård M; Kristiansen IS; Lynge E; Sparén P; Kim JJ; Burger EA
    Acta Obstet Gynecol Scand; 2018 Jul; 97(7):795-807. PubMed ID: 29388202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative analysis of cervical cancer prevention between Nigeria and Nordic countries that have experienced a decline in cervical cancer incidence.
    Anyasi HI; Foss AM
    Int Health; 2021 Jul; 13(4):307-317. PubMed ID: 33000170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
    Hristova L; Hakama M
    Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cervical cancer screening in Europe: Quality assurance and organisation of programmes.
    Elfström KM; Arnheim-Dahlström L; von Karsa L; Dillner J
    Eur J Cancer; 2015 May; 51(8):950-68. PubMed ID: 25817010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.
    Cuzick J; Arbyn M; Sankaranarayanan R; Tsu V; Ronco G; Mayrand MH; Dillner J; Meijer CJ
    Vaccine; 2008 Aug; 26 Suppl 10():K29-41. PubMed ID: 18847555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Introduction of human papillomavirus vaccination in Nordic countries.
    Sander BB; Rebolj M; Valentiner-Branth P; Lynge E
    Vaccine; 2012 Feb; 30(8):1425-33. PubMed ID: 22154773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The challenges of organising cervical screening programmes in the 15 old member states of the European Union.
    Arbyn M; Rebolj M; De Kok IM; Fender M; Becker N; O'Reilly M; Andrae B
    Eur J Cancer; 2009 Oct; 45(15):2671-8. PubMed ID: 19695867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age at last screening and remaining lifetime risk of cervical cancer in older, unvaccinated, HPV-negative women: a modelling study.
    Malagón T; Kulasingam S; Mayrand MH; Ogilvie G; Smith L; Bouchard C; Gotlieb W; Franco EL
    Lancet Oncol; 2018 Dec; 19(12):1569-1578. PubMed ID: 30392810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Implementation of DNA-HPV primary screening in Italian cervical cancer screening programmes. Results of the MIDDIR Project].
    Di Stefano F; Giorgi Rossi P; Carozzi F; Ronco G; Cacciani L; Vecchi S; Naldoni C; Segnan N;
    Epidemiol Prev; 2017; 41(2):116-124. PubMed ID: 28627153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary HPV testing versus cytology-based cervical screening in women in Australia vaccinated for HPV and unvaccinated: effectiveness and economic assessment for the National Cervical Screening Program.
    Lew JB; Simms KT; Smith MA; Hall M; Kang YJ; Xu XM; Caruana M; Velentzis LS; Bessell T; Saville M; Hammond I; Canfell K
    Lancet Public Health; 2017 Feb; 2(2):e96-e107. PubMed ID: 29253402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of cervical cancer screening.
    Pettersson F
    Med Oncol Tumor Pharmacother; 1991; 8(3):175-81. PubMed ID: 1803178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary HPV-based cervical cancer screening in Europe: implementation status, challenges, and future plans.
    Maver PJ; Poljak M
    Clin Microbiol Infect; 2020 May; 26(5):579-583. PubMed ID: 31539637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guidelines for Cervical Cancer Screening in Immunosuppressed Women Without HIV Infection.
    Moscicki AB; Flowers L; Huchko MJ; Long ME; MacLaughlin KL; Murphy J; Spiryda LB; Gold MA
    J Low Genit Tract Dis; 2019 Apr; 23(2):87-101. PubMed ID: 30907775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Icelandic and Nordic cervical screening programs: trends in incidence and mortality rates through 1995.
    Sigurdsson K
    Acta Obstet Gynecol Scand; 1999 Jul; 78(6):478-85. PubMed ID: 10376856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infrastructure requirements for human papillomavirus vaccination and cervical cancer screening in sub-Saharan Africa.
    Sankaranarayanan R; Anorlu R; Sangwa-Lugoma G; Denny LA
    Vaccine; 2013 Dec; 31 Suppl 5():F47-52. PubMed ID: 24331747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recommendations for cervical cancer prevention in Asia Pacific.
    Garland SM; Cuzick J; Domingo EJ; Goldie SJ; Kim YT; Konno R; Parkin DM; Qiao YL; Sankaranarayanan R; Stern PL; Tay SK; Bosch FX
    Vaccine; 2008 Aug; 26 Suppl 12():M89-98. PubMed ID: 18945418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of screening in the Nordic cancer control up to the year 2017.
    Hakama M; Hristova L
    Acta Oncol; 1997; 36(2):119-28. PubMed ID: 9140427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.